News Astellas suspended from UK pharma trade body ABPI takes action after finding firm misled investigation into its conduct.
News Brexit decision hits European pharma shares Shares of leading UK companies have plummeted after the country’s decision to leave the European Union.
News British pharma, biotech reiterate ‘Remain’ support On the eve of the hugely important referendum, the result is too close to call.
Views & Analysis Stay or go? The UK’s PPRS and the statutory scheme for prici... The latest Pharmaceutical Price Regulation Scheme (PPRS) is barely into its second year of operation but with rising payments to the Department of Health (DH) confirmed at the end of the first
News Ambrosia's sweet $100m round, and other biofinancings Our latest crop of biofinancings has a nine-figure round for Ambrosia, with Pinnacle Medicines, Immutrin, and Gilgamesh Pharma also raising new funds.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.
